Dr. Collin Kreple, a UW Health neurologist who delivered Francis’ tofersen injection in September, said it may take longer than the short period of the drug’s clinical trial to reveal its clinical effectiveness. Another study has started in people with SOD1 mutations who don’t have symptoms yet.
University Communications